Ameritas Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
3,254
-175
-5% -$84K 0.04% 462
2026
Q1
$1.69M Sell
3,429
-10
-0.3% -$5.43K 0.05% 405
2025
Q4
$1.99M Sell
3,439
-79
-2% -$44.7K 0.06% 338
2025
Q3
$1.71M Sell
3,518
-121
-3% -$56.3K 0.05% 388
2025
Q2
$1.48M Sell
3,639
-81
-2% -$33.9K 0.05% 458
2025
Q1
$1.85M Sell
3,720
-33
-0.9% -$17.9K 0.06% 353
2024
Q4
$1.95M Sell
3,753
-142
-4% -$78.1K 0.06% 343
2024
Q3
$2.41M Sell
3,895
-148
-4% -$87.6K 0.08% 267
2024
Q2
$2.24M Sell
4,043
-177
-4% -$101K 0.08% 265
2024
Q1
$2.45M Sell
4,220
-114
-3% -$64K 0.08% 261
2023
Q4
$2.3M Sell
4,334
-148
-3% -$71.6K 0.08% 258
2023
Q3
$2.27M Sell
4,482
-127
-3% -$67.7K 0.09% 227
2023
Q2
$2.4M Sell
4,609
-168
-4% -$90.7K 0.09% 226
2023
Q1
$2.75M Hold
4,777
0.11% 184
2022
Q4
$2.89M Sell
4,777
-85
-2% -$45K 0.12% 173
2022
Q3
$2.46M Sell
4,862
-47
-1% -$26.3K 0.11% 172
2022
Q2
$2.67M Sell
4,909
-162
-3% -$89.2K 0.12% 162
2022
Q1
$3M Sell
5,071
-136
-3% -$78.1K 0.11% 182
2021
Q4
$3.47M Sell
5,207
-147
-3% -$91.8K 0.12% 164
2021
Q3
$3.06M Sell
5,354
-39
-0.7% -$21.4K 0.11% 172
2021
Q2
$2.72M Sell
5,393
-90
-2% -$42.5K 0.1% 214
2021
Q1
$2.5M Sell
5,483
-306
-5% -$146K 0.1% 231
2020
Q4
$2.7M Sell
5,789
-379
-6% -$178K 0.12% 184
2020
Q3
$2.72M Sell
6,168
-239
-4% -$98.7K 0.12% 156
2020
Q2
$2.32M Sell
6,407
-235
-4% -$78.8K 0.11% 175
2020
Q1
$1.88M Sell
6,642
-147
-2% -$46.4K 0.11% 186
2019
Q4
$2.21M Sell
6,789
-68
-1% -$20.6K 0.1% 212
2019
Q3
$2M Sell
6,857
-137
-2% -$39.2K 0.09% 232
2019
Q2
$2.05M Sell
6,994
-272
-4% -$74.9K 0.09% 228
2019
Q1
$1.99M Hold
7,266
0.09% 239
2018
Q4
$1.63M Sell
7,266
-179
-2% -$42K 0.09% 263
2018
Q3
$1.82M Sell
7,445
-137
-2% -$31.5K 0.08% 282
2018
Q2
$1.57M Sell
7,582
-757
-9% -$161K 0.08% 327
2018
Q1
$1.72M Sell
8,339
-518
-6% -$109K 0.08% 300
2017
Q4
$1.75M Sell
8,857
-181
-2% -$34.7K 0.08% 301
2017
Q3
$1.69M Hold
9,038
0.08% 303
2017
Q2
$1.58M Sell
9,038
-156
-2% -$26.2K 0.08% 321
2017
Q1
$1.41M Sell
9,194
-445
-5% -$68K 0.07% 366
2016
Q4
$1.36M Hold
9,639
0.07% 375
2016
Q3
$1.53M Buy
9,639
+1,645
+21% +$253K 0.08% 301
2016
Q2
$1.18M Buy
7,994
+329
+4% +$48.6K 0.08% 255
2016
Q1
$1.08M Hold
7,665
0.07% 275
2015
Q4
$1.09M Buy
7,665
+204
+3% +$27.2K 0.07% 270
2015
Q3
$912K Hold
7,461
0.07% 297
2015
Q2
$968K Hold
7,461
0.06% 312
2015
Q1
$1M Hold
7,461
0.07% 300
2014
Q4
$935K Buy
7,461
+101
+1% +$12.3K 0.06% 309
2014
Q3
$896K Sell
7,360
-467
-6% -$56.8K 0.06% 317
2014
Q2
$924K Buy
7,827
+85
+1% +$10K 0.07% 315
2014
Q1
$931K Buy
7,742
+109
+1% +$13K 0.07% 307
2013
Q4
$850K Hold
7,633
0.07% 345
2013
Q3
$703K Buy
+7,633
New +$690K 0.07% 375

Other funds holding TMO

Ameritas Investment Partners's TMO Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Thermo Fisher Scientific (TMO) stake by 5.1% in Q2 2026, selling an estimated $84K and leaving 3,254 shares worth $1.63M. The position accounts for 0.04% of the portfolio, ranked #462.

Ameritas Investment Partners first reported a position in TMO in Q3 2013 and has held it in 52 quarters since. The position peaked at $3.47M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ameritas Investment Partners held 3,254 shares of Thermo Fisher Scientific worth $1.63M as of Q2 2026.
  • Ameritas Investment Partners sold 175 Thermo Fisher Scientific shares in Q2 2026, an estimated $84K.
  • Thermo Fisher Scientific made up 0.04% of Ameritas Investment Partners's portfolio in Q2 2026, its #462 holding.
  • Ameritas Investment Partners first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 52 quarters since.
  • Ameritas Investment Partners's Thermo Fisher Scientific position peaked at $3.47M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.